A recent review paper published in MDPI proposed a comprehensive, expert verified taxonomy of ECG monitoring systems by conducting a systemic review of the literature around continuous Cardiac monitoring. This review provides evidence-based support for critically understanding ECG monitoring systems’ components, contexts, features, and challenges. · Current developments in ECG
A 72-year-old male presented in OPD with chief complaints of shortness of breath and palpitations. On laboratory evaluation, his blood parameters were within normal limits. ECG showed frequent PVCs and dilated cardiomyopathy was reported in ECHO. He was put on VIGO SmartHeart long term ECG monitoring, which showed 3802 non
A recent randomized trial results published in JAMA revealed that continuous ECG monitoring of post-op cardiac surgery patients at a high risk of stroke and no preoperative AF showed a significant increase in the rate of Post operative atrial fibrillation (PAOF) that would otherwise have not been detected by usual
A 35-year-old male with a past medical history of hypertension, asthma and hyperlipidemia presented to the emergency department with a chief complaint of syncope preceded by headache. On physical examination, no focal neurologic deficits were found. His vitals at that time showed a blood pressure of 141/82 mmHg, heart rate
A 56‐year‐old woman with diarrhea and fever for 4 days was confirmed to have COVID‐19 pneumonia via chest CT. She denied a history of chronic illness and related medications. Patient was advised for Vigo multivital monitoring for COVID recovery. The patient was treated with oral antiviral lopinavir/ritonavir 400/100 mg twice
A 76-year-old male with hypertension and diabetes, presented with complaints of rapid palpitations. During his detailed evaluation, the biochemical parameters were within normal limits. Initial ECG and echocardiogram were normal. Long-term ECG monitoring with Vigo SmartHeart Showed Supraventricular Tachycardia episodes at 180 beats per minute. The patient was treated in
Pacing indications differ in male and female, thus separate indications are suggested. Pacing indications evaluation criteria have been modified. Carotid massage is recommended in patients for syncope, where other pathological causes are ruled out. Noninvasive modalities like 12 lead ECG monitoring, exercise testing, multimodality imaging to remain the mainstay for
COVID-19 INTRODUCTION In December 2019, the COVID-19 pandemic due to SARS-CoV-2 began in China and the world health organization declared it as a public health emergency of international concern on January 30, 2020. India has reported the first case of COVID-19 on January 30, 2020. During this pandemic, there was
Case Study: A 28 years old female presented in the OP with complains of palpitations and giddiness. There was a positive history of anxiety, chest pain and episodes of fainting. The presentation was ideal for holter monitoring to narrow down the diagnosis. She was prescribed a 5 day smart heart holter
Dr. Sowjanya is specialized in Emergency Medicine with an experience of over 15 years spanning across the emergency and critical care practices. She has served as Chief Coordinator of QA Activities through NABH / JCI Accreditations at Continental Hospital and as Full Assessor for NABH and Member of the Association of Physician Leaders, USA.
Dr. Sowjanya has been involved with various professional bodies like the American Heart Association, International Federation of Emergency Medicine (IFEM), American College of Emergency Physicians and many more. She is currently the National Treasurer for Society for Emergency Medicine India (SEMI), as well as Secretary (SIG) – Gender Specific Issues.
As the CMO at Vigocare, Dr. Sowjanya drives Clinical Research & Product Strategy to drive development of cutting-edge solutions.
Advisor
Dr. Lee serves as a Professor, Medicine at the University of California, San Francisco, is a Cardiologist and a Cardiac Electrophysiologist who specializes in the treatment of arrhythmias and prevention of stroke. He finished his clinical training in cardiac electrophysiology at the University of California, San Francisco in 1992.
In addition to the development of devices and techniques for the treatment of arrhythmias and embolic stroke prevention, Dr.Lee has an active cardiac tissue engineering laboratory for myocardial repair/reconstruction; and a program for applying AI/ML for the detection of arrhythmias and patient wellbeing.
CTO
Mr. Akkiraju brings over twenty years of experience to Vigocare, spanning a mix of enterprise and entrepreneurship.
As CTO, Akki is the Solutions owner – he oversees all software and AI engineering. He enjoys building highly technical teams and leading them to deliver technology, products, and solutions via painstakingly built methodologies.
Akki also spearheads R&D and data science partnerships at Vigocare. His vision for Vigocare is to improve the quality of patient care manifold by providing reliable, accurate insights using data science.
FOUNDER / CEO
Dr. Sekhar is a maxillofacial surgeon by qualification and a serial entrepreneur by passion. He has over 18 years of experience in building consumer-focused, scale organisations across healthcare and technology sectors. He is renowned for building A+ teams and spearheading a wide spectrum of challenging business environments to build businesses from the ground up.
As the CEO, Sekhar brings vision and medical expertise to the table. Vigocare is very close to his heart – he envisions connecting care providers with millions of people globally, without borders, and enabling timely decisions ahead of the disease – pushing people to the right action, at the right time.
